Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 8 studies | 29% ± 16% | |
respiratory goblet cell | 7 studies | 52% ± 15% | |
club cell | 6 studies | 40% ± 23% | |
epithelial cell | 5 studies | 41% ± 17% | |
mesothelial cell | 5 studies | 25% ± 8% | |
retinal pigment epithelial cell | 5 studies | 51% ± 11% | |
Mueller cell | 5 studies | 35% ± 12% | |
secretory cell | 4 studies | 41% ± 9% | |
basal cell | 4 studies | 37% ± 16% | |
ciliated cell | 4 studies | 37% ± 11% | |
renal principal cell | 4 studies | 28% ± 15% | |
squamous epithelial cell | 3 studies | 54% ± 18% | |
smooth muscle cell | 3 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3305.07 | 1442 / 1445 | 98% | 47.29 | 180 / 183 |
stomach | 100% | 3689.22 | 359 / 359 | 98% | 33.30 | 280 / 286 |
intestine | 100% | 2548.23 | 966 / 966 | 97% | 33.42 | 513 / 527 |
liver | 100% | 3320.82 | 226 / 226 | 97% | 43.37 | 395 / 406 |
lung | 99% | 2388.65 | 573 / 578 | 97% | 70.95 | 1120 / 1155 |
pancreas | 97% | 1345.15 | 317 / 328 | 93% | 33.60 | 166 / 178 |
bladder | 100% | 3623.43 | 21 / 21 | 89% | 37.68 | 451 / 504 |
kidney | 100% | 2949.74 | 89 / 89 | 89% | 29.57 | 803 / 901 |
uterus | 94% | 1202.40 | 159 / 170 | 92% | 68.81 | 424 / 459 |
breast | 98% | 1911.04 | 450 / 459 | 72% | 36.72 | 808 / 1118 |
prostate | 100% | 3911.71 | 244 / 245 | 71% | 15.15 | 355 / 502 |
thymus | 98% | 1148.17 | 640 / 653 | 61% | 11.61 | 367 / 605 |
skin | 90% | 1139.05 | 1626 / 1809 | 35% | 8.56 | 166 / 472 |
ovary | 78% | 746.81 | 140 / 180 | 40% | 11.25 | 174 / 430 |
adrenal gland | 92% | 988.22 | 238 / 258 | 23% | 5.70 | 52 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.12 | 1 / 1 |
adipose | 99% | 3852.03 | 1193 / 1204 | 0% | 0 | 0 / 0 |
brain | 45% | 415.61 | 1201 / 2642 | 53% | 22.62 | 376 / 705 |
tonsil | 0% | 0 | 0 / 0 | 93% | 46.02 | 42 / 45 |
spleen | 92% | 899.81 | 221 / 241 | 0% | 0 | 0 / 0 |
heart | 89% | 1123.72 | 763 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 79% | 912.00 | 1052 / 1335 | 0% | 0 | 0 / 0 |
muscle | 64% | 461.20 | 514 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 5.82 | 11 / 29 |
eye | 0% | 0 | 0 / 0 | 24% | 4.53 | 19 / 80 |
peripheral blood | 3% | 24.78 | 32 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007601 | Biological process | visual perception |
GO_0060431 | Biological process | primary lung bud formation |
GO_0008406 | Biological process | gonad development |
GO_0001701 | Biological process | in utero embryonic development |
GO_1900054 | Biological process | positive regulation of retinoic acid biosynthetic process |
GO_0060449 | Biological process | bud elongation involved in lung branching |
GO_0001656 | Biological process | metanephros development |
GO_0035115 | Biological process | embryonic forelimb morphogenesis |
GO_0014032 | Biological process | neural crest cell development |
GO_0043584 | Biological process | nose development |
GO_0001523 | Biological process | retinoid metabolic process |
GO_0048703 | Biological process | embryonic viscerocranium morphogenesis |
GO_0042574 | Biological process | retinal metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0031076 | Biological process | embryonic camera-type eye development |
GO_0002138 | Biological process | retinoic acid biosynthetic process |
GO_0043583 | Biological process | ear development |
GO_0005811 | Cellular component | lipid droplet |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0052650 | Molecular function | all-trans-retinol dehydrogenase (NADP+) activity |
GO_0004745 | Molecular function | all-trans-retinol dehydrogenase (NAD+) activity |
GO_0005515 | Molecular function | protein binding |
GO_0016616 | Molecular function | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
Gene name | RDH10 |
Protein name | NADP-retinol dehydrogenase (EC 1.1.1.300) Retinol dehydrogenase 10 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 16C member 4) |
Synonyms | UNQ9375/PRO34191 SDR16C4 |
Description | FUNCTION: Retinol dehydrogenase with a clear preference for NADP. Converts all-trans-retinol to all-trans-retinal. Has no detectable activity towards 11-cis-retinol, 9-cis-retinol and 13-cis-retinol. . |
Accessions | ENST00000521928.5 E5RK48 ENST00000240285.10 E5RHJ9 Q8IZV5 ENST00000519380.1 |